Detalhe da pesquisa
1.
A quality-adjusted survival time without symptoms or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy.
Cancer
; 126(19): 4315-4321, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32697335
2.
Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.
Cancer
; 124(10): 2151-2160, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508899
3.
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study.
Eur J Cancer
; 196: 113420, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000218
4.
Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1.
Eur Urol
; 83(4): 352-360, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750582
5.
Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis.
Am J Otolaryngol
; 31(1): 1-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-19944891
6.
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.
JNCI Cancer Spectr
; 4(1): pkz085, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32337496
7.
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
Clin Infect Dis
; 43(10): 1264-71, 2006 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17051490
8.
Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial.
Cancer Med
; 3(5): 1353-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25044922
9.
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Clin Ther
; 34(8): 1667-73.e1, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22770644
10.
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
Am J Surg
; 199(6): 804-16, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20227056
11.
Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
Chest
; 134(6): 1200-1207, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18719064
12.
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.
Ann Intern Med
; 136(1): 13-24, 2002 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11777360